Vascular endothelial growth factor in diabetic retinopathy [5]

Lancet

Volumn 349, Issue 9064, 1997, Pages 1520-

  Tanaka, Yoshikazu ^b,c   Katoh, Satoshi ^b,c   Hori, Sadao ^b,c   Miura, Masakazu ^b,c   Yamashita, Hidetoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; VASCULOTROPIN;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; BLOOD RETINA BARRIER; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

EID: 0343742564     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62099-5     Document Type: Article

References (3)

1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-87.
2. Murata T, Nakagawa K, Khalel A, et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996; 74: 819-25.
3. Sawa M, Tsurimaki Y, Tsuru T, et al. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol 1988; 32: 132-42.